Q: can you shed light on the reasons why this stock dropped over 5% over yesterday and today? I didn't see any news from the FDA or news
on advances made by the competition. Is iit the sector in general? Is it a good time to buy?
Really appreciate your perspectives and common sense.
Thanks
Q: Considering the tone if the release this morning on Knight's Directors, I would take a wild guess it was commissioned by Jakobsohn.
Goodman put his pharmascience shares in a blind trust. This NR is no big deal...
Q: Today’s press release about Dr. Leblanc governance report , is negative. I don’t see the date he submitted his report. Would you know ?
Can you comment on this, do you still think J Goodman will win the proxy fight, and will he make any changes should he win.
Thanks,
Q: Hello,
I need to increase my health care exposure and also diversify into the US .
What is your opinion on these two Etf’s, or would you recommend individual stocks and if so which ones.
Thank you
Q: I have PLI shares in my TFSA and RRSP. Will they be eligible to participate in the rights offering and does the financial transaction occur within these accounts.
Q: Hi. I can see that Dave has just asked my question about selling GUD given its current turmoil... so I won't ask that; however, even with keeping GUD I have too little exposure in the health care sector bc I sold JJ in January. Can you provide the names of any Canadian Health Care companies I could check out. Thanks,
Q: Shareholders of Prometic are being offered a rights issuance where each existing share owned will allow you to buy 20 shares at 1.5 cents. It is trading at 7 cents now real time. Am I missing something or should I jump at the deal. I thought the trading price would instantly come down to the dilution price mentioned in the release.
Q: Prometric announced a restructuring today , It seems like a lot of parts to it.
Can you explain the elements to it and point out the positives and negatives to the deal.
It seems more complicated then the Bellatrix deal.
Thanks
Q: GIVEN THE MESS THAT IS COMING IN THE MAY MEETING, WHAT DO YOU SEE HAPPENING? IS THERE A BUYING OPPORTUNITY HERE IF THERE IS FAITH IN GUD.....OR A SIT TIGHT... OR A SELL?
THANKS IN ADVANCE.
Q: ARKG :ARK Genomic Revolution ETF ... I have done very well and continue to do well with this etf which invests in leading edge companies in applied biotechnology . Oddly, you haven’t ever commented on this etf and I can’t even enter it in my analytics package .